BILL ANALYSIS Ó SB 1301 Page 1 Date of Hearing: August 8, 2012 ASSEMBLY COMMITTEE ON APPROPRIATIONS Felipe Fuentes, Chair SB 1301 (Hernández) - As Amended: August 6, 2012 Policy Committee: HealthVote:18-0 Business and Professions Vote: 9-0 Urgency: No State Mandated Local Program: No Reimbursable: No SUMMARY This bill allows a pharmacist to dispense up to a 90-day supply of a prescribed drug, excluding controlled substances, if the patient has completed an initial 30-day supply of the drug and other requirements are satisfied, as specified. It also specifies it does not require a health care service plan, health insurer, workers' compensation insurance plan, pharmacy benefits manager, or any other person or entity, including, but not limited to, a state program or state employer, to provide drug coverage in a manner inconsistent with a beneficiary's plan benefit. FISCAL EFFECT Negligible state fiscal effect. COMMENTS 1)Rationale . The author believes that allowing patients to receive up to 90 days of a prescription refill will make it easier for them to adhere to their treatment and live healthier lives while reducing costs throughout the health care system. Additionally, he points to consumer benefit from increased convenience and possible fewer copayments at the pharmacy. The California Retailers Association is the sponsor of this measure. 2)Background . Currently, pharmacists must seek authorization from a prescriber before dispensing more than a 30-day prescription unless a larger amount is prescribed initially. SB 1301 Page 2 Retailers report that often, prescribers cannot be reached for authorization, leaving individuals with only a 30-day supply which must then be refilled. Studies have found potential cost savings related to dispensing larger amounts of certain drugs. Generally, drugs for which prescription adherence is important, that are lower-cost per dose, and/or that are related to controlling chronic conditions are thought to be better candidates for larger dosages from a health care cost perspective. This bill does not require health plans to cover a 90-day supply, suggesting that plans and pharmacy benefit managers would retain control over which drugs are reimbursed in larger quantities than 30 days. Analysis Prepared by : Lisa Murawski / APPR. / (916) 319-2081